OptiNose, Inc.·4

Feb 26, 8:00 PM ET

Kohler Terry 4

4 · OptiNose, Inc. · Filed Feb 26, 2025

Insider Transaction Report

Form 4
Period: 2025-02-21
Kohler Terry
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2025-02-21+13,87523,875 total
  • Award

    Stock Option (Right to Buy)

    2025-02-21+6,9506,950 total
    Exercise: $5.77Exp: 2035-02-21Common Stock (6,950 underlying)
Footnotes (2)
  • [F1]Represents the grant of restricted stock units (RSUs). Twenty-five percent (25%) of the RSUs vest on February 21, 2026, and the balance vests in equal quarterly installments over the remaining three years of the four year period, subject to continued service with the Issuer. Each RSU represents the right to receive one share of common stock of OptiNose, Inc.
  • [F2]The option vests and becomes exercisable over a four-year period commencing on February 21, 2025. Twenty-five percent (25%) of the option vests and becomes exercisable on February 21, 2026, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer.

Documents

1 file
  • 4
    wk-form4_1740618037.xmlPrimary

    FORM 4